Stock ABSI ABSCI CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Absci Corporation

Equities

ABSI

US00091E1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
4.53 USD -3.82% Intraday chart for Absci Corporation -14.37% +7.86%
Mar. 21 Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000 MT
Mar. 21 Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
GL
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
AQ
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000
MT
Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Absci Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
GL
Scotiabank Starts Absci With Sector Outperform Rating, $13 Price Target
MT
KeyBanc Raises Price Target on Absci to $8 From $5, Keeps Overweight Rating
MT
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GL
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
AQ
Absci Announces Pricing of Public Offering of Common Stock
GL
Absci Announces Proposed Public Offering of Common Stock
GL
Absci Announces Proposed Public Offering of Common Stock
AQ
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
GL
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
AQ
Absci Initiates IND-Enabling Studies for Abs-101, A Potential Best-In-Class Anti-Tl1a Antibody De Novo Designed and Optimized Using Generative Ai
CI
Absci to Participate in Upcoming Investor Conferences
GL
Transcript : Absci Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 10:30 AM
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABSI Stock
  4. News Absci Corporation